Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · IEX Real-Time Price · USD
8.17
-0.12 (-1.45%)
At close: Apr 19, 2024, 4:00 PM
8.00
-0.17 (-2.08%)
After-hours: Apr 19, 2024, 7:37 PM EDT
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -64.48% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for OTLK stock have an average target of 46.43, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 468.30% from the current stock price of 8.17.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OTLK stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +512.00% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +267.20% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +634.39% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +389.60% | Jan 25, 2024 |
| Brookline Capital | Brookline Capital | Hold → Strong Buy Upgrades $31 | Hold → Strong Buy | Upgrades | $31 | +284.33% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
242.42K
Revenue Next Year
13.36M
from 242.42K
Increased by 5,409.78%
EPS This Year
-3.34
from -4.80
EPS Next Year
-2.06
from -3.34
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.5M | 33.3M | 142.9M | 742.0M | 1.1B |
| Avg | 242,423 | 13.4M | 94.3M | 402.4M | 556.1M |
| Low | n/a | n/a | 66.8M | 98.8M | 160.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 13,628.5% | 969.8% | 687.3% | 177.6% |
| Avg | - | 5,409.8% | 605.6% | 327.0% | 38.2% |
| Low | - | - | 399.8% | 4.8% | -60.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.10 | -0.89 | 1.40 | 1.22 | 2.04 |
| Avg | -3.34 | -2.06 | -0.16 | 0.45 | 0.79 |
| Low | -3.85 | -2.94 | -1.38 | -0.12 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 353.9% |
| Avg | - | - | - | - | 75.0% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.